JUN 9, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Linezolid (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for linezolid labeling change; does not report clinical trial outcomes or comparative efficacy data.
Reported
Formulation strength600 mg/300 mL (2 mg/mL)
Approval date2026-06-09